Health and Fitness Health and Fitness
Tue, July 31, 2012
[ Tue, Jul 31st 2012 ] - Market Wire
Calyx Announces Closing of First Tranche of Private Placement
[ Tue, Jul 31st 2012 ] - Market Wire
Alseres Pharmaceuticals, Inc. Reports License of .. ldwide Rights to Navidea Biopharmaceuticals, Inc.
[ Tue, Jul 31st 2012 ] - Market Wire
Depomed Announces Submission Of Serada NDA
[ Tue, Jul 31st 2012 ] - Market Wire
Orexigen Therapeutics Schedules August 7, 2012 We .. Results for the Second Quarter Ended June 30, 20
[ Tue, Jul 31st 2012 ] - Market Wire
New York Genome Center Purchases Four Ion Protona" Sequencers for its new Innovation Center
[ Tue, Jul 31st 2012 ] - Market Wire
Neurocrine Biosciences Reports Second Quarter 2012 Results
[ Tue, Jul 31st 2012 ] - Market Wire
MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
[ Tue, Jul 31st 2012 ] - Market Wire
Optigenex Inc. Announces Settlement With Secured Note Holders
[ Tue, Jul 31st 2012 ] - Market Wire
Hospira Expands Board of Directors With Election of Dennis M. Fenton
[ Tue, Jul 31st 2012 ] - Market Wire
Synergy Pharmaceuticals to Present Scientific Pos .. nterology Society Meetings in the U.S. and Europe
[ Tue, Jul 31st 2012 ] - Market Wire
Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2012
[ Tue, Jul 31st 2012 ] - Market Wire
Mylan Specialty L.P. Partners with the Pittsburgh .. Sponsor PNC Park's First Allergy Awareness Night
[ Tue, Jul 31st 2012 ] - Market Wire
Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
[ Tue, Jul 31st 2012 ] - Market Wire
Fresh Start Private Announces New Web Presence
[ Tue, Jul 31st 2012 ] - Market Wire
BIOLASE Establishes Long-Term Collaboration With .. y Expert Professor Norbert Gutknecht and the Aach
[ Tue, Jul 31st 2012 ] - Market Wire
Ohr Pharmaceutical Issues Letter to Shareholders
[ Tue, Jul 31st 2012 ] - Market Wire
China Cord Blood Corporation Files its Annual Report on Form 20-F
[ Tue, Jul 31st 2012 ] - Market Wire
Sarepta Therapeutics Announces Second Quarter 201 .. cial Results and Corporate Update Conference Call
[ Tue, Jul 31st 2012 ] - Market Wire
CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility
[ Tue, Jul 31st 2012 ] - Market Wire
Aethlon Medical Reports Undetectable Hepatitis C .. Initiation of Hemopurifier Therapy in Genotype-1
[ Tue, Jul 31st 2012 ] - Market Wire
Zynex Schedules Second Quarter 2012 Earnings Release and Webcast
[ Tue, Jul 31st 2012 ] - Market Wire
La Jolla Pharmaceutical Company Announces FDA Agr .. Clinical Trial of GCS-100 in Chronic Kidney Disea
[ Tue, Jul 31st 2012 ] - Market Wire
Rockwell Medical Completes Patient Enrollment in .. ls for SFP Iron-Delivery in Hemodialysis Patients
[ Tue, Jul 31st 2012 ] - Market Wire
Novadaq to Present at the Canaccord Genuity 32nd Annual Growth Conference
[ Tue, Jul 31st 2012 ] - Market Wire
FDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing
[ Tue, Jul 31st 2012 ] - Market Wire
Omeros Announces Discovery in MASP-2 Program
Mon, July 30, 2012
[ Mon, Jul 30th 2012 ] - Market Wire
Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
[ Mon, Jul 30th 2012 ] - Market Wire
Acura Pharmaceuticals Announces Second Quarter 2012 Financial Results
[ Mon, Jul 30th 2012 ] - Market Wire
Amerigroup Leadership Honored to Serve on Higher Education Boards
[ Mon, Jul 30th 2012 ] - Market Wire
diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results

diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results


Published on 2012-07-30 13:21:39 - Market Wire
  Print publication without navigation


diaDexus, Inc. to Host Webcast August 7, 2012 on Second... -- SOUTH SAN FRANCISCO, Calif., July 30, 2012 /PRNewswire/ --

diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results

[ ]

SOUTH SAN FRANCISCO, Calif., July 30, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: [ DDXS ]), a diagnostics company focused on the development and commercialization of proprietary diagnostic products, today announced that it will host a webcast on Tuesday, August 7 at 4:15 PM ET (1:15 PM PT) to discuss its 2012 second quarter results. The webcast may be accessed via the company's website at [ www.diadexus.com/webcast ].

About diaDexus, Inc.

diaDexus, Inc., based in South San Francisco, California, is focused on the development and commercialization of proprietary diagnostic products addressing unmet needs in cardiovascular disease. The company's PLAC ELISA Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis, the #1 and #3 causes of death, respectively, in the United States. For more information, please visit the company's website at [ www.diaDexus.com ].

SOURCE diaDexus, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.diadexus.com ]

Contributing Sources